Atorvastatin treatment improves the effects of mesenchymal stem cell transplantation on acute myocardial infarction: The role of the RhoA/ROCK/ERK pathway

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 670-679

  Zhang, Qian ^a   Wang, Hong ^a   Yang, Yue Jin ^a   Dong, Qiu Ting ^a   Wang, Tian Jie ^a   Qian, Hai Yan ^a   Li, Na ^a   Wang, Xi Mei ^a   Jin, Chen ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Acute myocardial infarction; Atorvastatin; Extracellular regulated protein kinase; Fasudil; Mesenchymal stem cells; Rho associated coiled coil forming kinase

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; ECHOGRAPHY; ENZYMOLOGY; FEMALE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; PHYSIOLOGY; PROCEDURES; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; CELLS, CULTURED; FEMALE; HEPTANOIC ACIDS; MALE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; TREATMENT OUTCOME;

EID: 84908241065     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.071     Document Type: Article

References (49)

1. J.H. Houtgraaf, R. de Jong, K. Kazemi, D. de Groot, T.I. van der Spoel, and F. Arslan Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function Circ. Res. 113 2 2013 153 166
2. C. Peng, K. Yang, P. Xiang, C. Zhang, L. Zou, and X. Wu Effect of transplantation with autologous bone marrow stem cells on acute myocardial infarction Int. J. Cardiol. 162 3 2013 158 165
3. S. Janssens, C. Dubois, J. Bogaert, K. Theunissen, C. Deroose, and W. Desmet Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial Lancet 367 9505 2006 113 121
4. L.R. Gao, X.T. Pei, Q.A. Ding, Y. Chen, N.K. Zhang, and H.Y. Chen A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction Int. J. Cardiol. 168 4 2013 3191 3199
5. B. Cai, J. Li, J. Wang, X. Luo, J. Ai, and Y. Liu microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling Stem Cells 30 8 2012 1746 1755
6. G. Siegel, P. Krause, S. Wohrle, P. Nowak, M. Ayturan, and T. Kluba Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential Stem Cells Dev. 21 13 2012 2457 2470
7. K. Bai, Y. Huang, X. Jia, Y. Fan, and W. Wang Endothelium oriented differentiation of bone marrow mesenchymal stem cells under chemical and mechanical stimulations J. Biomech. 43 6 2010 1176 1181
8. J. Otto Beitnes, E. Oie, A. Shahdadfar, T. Karlsen, R.M. Muller, and S. Aakhus Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function Cell Transplant. 21 8 2012 1697 1709
9. H.C. Quevedo, K.E. Hatzistergos, B.N. Oskouei, G.S. Feigenbaum, J.E. Rodriguez, and D. Valdes Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity Proc. Natl. Acad. Sci. U. S. A. 106 33 2009 14022 14027
10. N. Noiseux, M. Gnecchi, M. Lopez-Ilasaca, L. Zhang, S.D. Solomon, and A. Deb Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation Mol. Ther. J. Am. Soc. Gene Ther. 14 6 2006 840 850
11. K. Wu, S. Tian, H. Zhou, and Y. Wu Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation Biochem. Pharmacol. 85 12 2013 1753 1760
12. H.L. Liu, Y. Yang, S.L. Yang, J.P. Luo, H. Li, and L.M. Jing Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study Clin. Ther. 35 3 2013 261 272
13. N. Katsiki, D.P. Mikhailidis, and M. Banach Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels J. Hypertens. 29 12 2011 2493 2494 [author reply 2494]
14. Y.J. Yang, H.Y. Qian, J. Huang, Y.J. Geng, R.L. Gao, and K.F. Dou Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts Eur. Heart J. 29 12 2008 1578 1590
15. L. Song, Y.J. Yang, Q.T. Dong, H.Y. Qian, R.L. Gao, and S.B. Qiao Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase PLoS One 8 5 2013 e65702
16. Q. Zhang, Y.J. Yang, H. Wang, Q.T. Dong, T.J. Wang, and H.Y. Qian Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway Stem Cells Dev. 21 8 2012 1321 1332
17. H. Xu, Y.J. Yang, H.Y. Qian, Y.D. Tang, H. Wang, and Q. Zhang Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts Circ. J.J. Jpn. Circ. Soc. 75 6 2011 1476 1485
18. P. Tsounapi, M. Saito, K. Kitatani, F. Dimitriadis, F. Ohmasa, and S. Shimizu Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats Eur. J. Pharmacol. 691 1-3 2012 182 189
19. M. Ruperez, R. Rodrigues-Diez, L.M. Blanco-Colio, E. Sanchez-Lopez, J. Rodriguez-Vita, and V. Esteban HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways Hypertension 50 2 2007 377 383
20. T.E. Robey, M.K. Saiget, H. Reinecke, and C.E. Murry Systems approaches to preventing transplanted cell death in cardiac repair J. Mol. Cell. Cardiol. 45 4 2008 567 581
21. M. Gnecchi, H. He, N. Noiseux, O.D. Liang, L. Zhang, and F. Morello Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement J.Publ. Fed.Am. Soc. Exp.Biol. 20 6 2006 661 669
22. S. Zuo, W.K. Jones, H. Li, Z. He, Z. Pasha, and Y. Yang Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury Stem Cells Dev. 21 4 2012 598 608
23. J.Y. Hahn, H.J. Cho, H.J. Kang, T.S. Kim, M.H. Kim, and J.H. Chung Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction J. Am. Coll. Cardiol. 51 9 2008 933 943
24. I. Rosova, M. Dao, B. Capoccia, D. Link, and J.A. Nolta Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells Stem Cells 26 8 2008 2173 2182
25. Y. Wang, G. Zhang, Y. Hou, J. Chen, J. Wang, and C. Zou Transplantation of microencapsulated Schwann cells and mesenchymal stem cells augment angiogenesis and improve heart function Mol. Cell. Biochem. 366 1-2 2012 139 147
26. M. Mirotsou, Z. Zhang, A. Deb, L. Zhang, M. Gnecchi, and N. Noiseux Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair Proc. Natl. Acad. Sci. U. S. A. 104 5 2007 1643 1648
27. R.C. Lai, F. Arslan, M.M. Lee, N.S. Sze, A. Choo, and T.S. Chen Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury Stem Cell Res. 4 3 2010 214 222
28. X.L. Tang, D.G. Rokosh, Y. Guo, and R. Bolli Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction Circ.J. Off. J. Jpn.Circ. Soc. 74 3 2010 390 404
29. F. Dong, J. Harvey, A. Finan, K. Weber, U. Agarwal, and M.S. Penn Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction Circulation 126 3 2012 314 324
30. M.N. Islam, S.R. Das, M.T. Emin, M. Wei, L. Sun, and K. Westphalen Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury Nat. Med. 18 5 2012 759 765
31. A. Acquistapace, T. Bru, P.F. Lesault, F. Figeac, A.E. Coudert, and O. le Coz Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer Stem Cells 29 5 2011 812 824
32. M. Dong, B.P. Yan, J.K. Liao, Y.Y. Lam, G.W. Yip, and C.M. Yu Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases Drug Discov. Today 15 15-16 2010 622 629
33. N. Sawada, and J.K. Liao Rho/ROCK pathway as therapeutic targets for statins in atherosclerosis 2013 Antioxidants & redox signaling
34. Y. Rikitake, and J.K. Liao Rho GTPases, statins, and nitric oxide Circ. Res. 97 12 2005 1232 1235
35. R. Merla, Y. Ye, Y. Lin, S. Manickavasagam, M.H. Huang, and R.J. Perez-Polo The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation Am. J. Physiol. Heart Circ. Physiol. 293 3 2007 H1918 H1928
36. X. Xu, L. Zhang, and J. Liang Rosuvastatin prevents pressure overloadinduced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats Mol. Med. Rep. 8 2 2013 385 392
37. N. Takayama, H. Kai, H. Kudo, S. Yasuoka, T. Mori, and T. Anegawa Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways Hypertens. Res. Off. J. Japan. Soc. Hypertens. 34 3 2011 341 347
38. N. Wang, P. Guan, J.P. Zhang, Y.Q. Li, Y.Z. Chang, and Z.H. Shi Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways J. Cell. Biochem. 112 7 2011 1920 1929
39. A. Shatanawi, M.J. Romero, J.A. Iddings, S. Chandra, N.S. Umapathy, and A.D. Verin Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway Am. J. Physiol. Cell Physiol. 300 5 2011 C1181 C1192
40. S. Wolfrum, A. Dendorfer, Y. Rikitake, T.J. Stalker, Y. Gong, and R. Scalia Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection Arterioscler. Thromb. Vasc. Biol. 24 10 2004 1842 1847
41. S. Van Linthout, A. Riad, N. Dhayat, F. Spillmann, J. Du, and S. Dhayat Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy Diabetologia 50 9 2007 1977 1986
42. C.A. Efthymiou, M.M. Mocanu, and D.M. Yellon Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling J. Cardiovasc. Pharmacol. 45 3 2005 247 252
43. A.W. Heldman, D.L. DiFede, J.E. Fishman, J.P. Zambrano, B.H. Trachtenberg, and V. Karantalis Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial JAMA 311 1 2014 62 73
44. A. Tzouvelekis, V. Paspaliaris, G. Koliakos, P. Ntolios, E. Bouros, and A. Oikonomou A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis J. Transl. Med. 11 2013 171
45. M.M. Bonab, M.A. Sahraian, A. Aghsaie, S.A. Karvigh, S.M. Hosseinian, and B. Nikbin Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study Curr. Stem Cell Res. Ther. 7 6 2012 407 414
46. J.A. Perez-Simon, O. Lopez-Villar, E.J. Andreu, J. Rifon, S. Muntion, and M.D. Campelo Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial Haematologica 96 7 2011 1072 1076
47. M. Strioga, S. Viswanathan, A. Darinskas, O. Slaby, and J. Michalek Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells Stem Cells Dev. 21 14 2012 2724 2752
48. K. Le Blanc, C. Tammik, K. Rosendahl, E. Zetterberg, and O. Ringden HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells Exp. Hematol. 31 10 2003 890 896
49. X.P. Huang, Z. Sun, Y. Miyagi, H. McDonald Kinkaid, L. Zhang, and R.D. Weisel Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair Circulation 122 23 2010 2419 2429